Trial Profile
Virological and clinical anti-HBV [hepatitis B virus] efficacy of tenofovir and emtricitabine in antiretroviral naive patients with HIV/HBV co-infection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Emtricitabine (Primary) ; Tenofovir (Primary) ; Efavirenz; Zidovudine
- Indications Hepatitis B; HIV infections
- Focus Therapeutic Use
- 14 Nov 2005 New trial record.